Silver Book Fact

Late Mortality and Sepsis

Compared with patients not in the hospital, sepsis in hospitalized patients was associated with a 22.1%  increase in late mortality during a 2 year follow-up period.

Late Mortality After Sepsis: Propensity matched cohort study. BMJ. 2016; 353. http://www.bmj.com/content/353/bmj.i2375

Reference

Title
Late Mortality After Sepsis: Propensity matched cohort study
Publication
BMJ
Publication Date
2016
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • Drug-resistant MRSA expensive to treat
    As an example, the median treatment cost for drug-resistant MRSA patients over a 6-month period was 118% higher than the cost of treating drug-susceptible MRSA strains.  
  • Significant increase of penicillin-resistant Streptococcus penumoniae
    High-level penicillin-resistant Steptococcus pneumoniae increased 1,000-fold over 17 years.  
  • Enormous annual direct cost of HAIs to hospitals
    The annual direct cost of healthcare-associated infections to U.S. hospitals ranges from $28.4 billion to $45 billion.  
  • HAI Annual Cost
    Healthcare-associated infections in US hospitals cost $96–$147 billion annually.  
  • Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually
    Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.